Pharmacogenomics (Record no. 1503)

MARC details
000 -LEADER
fixed length control field 03377nam a2200517 a 4500
001 - CONTROL NUMBER
control field scn00350024
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210413150551.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m|||||||||||||||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr||n||||||||n
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 161024s2013||||nyu|||||s|||||||||||eng||
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2012024941
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0071741690 (eISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780071741699 (e-ISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781283656160 (print-ISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1283656167 (print-ISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 6613968668
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9786613968661
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)793223356
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.3.G45
Item number P43 2013
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number 2012 I-854
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 38.5
Item number P534 2013
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1/9
Edition number 23
245 00 - TITLE STATEMENT
Title Pharmacogenomics
Medium [electronic resource] :
Remainder of title an introduction and clinical perspective /
Statement of responsibility, etc. edited by Joseph S. Bertino Jr, C. Lindsay DeVane, Uwe Fuhr, Angela D. M. Kashuba, Joseph D. Ma.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. New York, N.Y. :
Name of publisher, distributor, etc. McGraw-Hill Education LLC.,
Date of publication, distribution, etc. c2013.
300 ## - PHYSICAL DESCRIPTION
Extent xiii, 274 p. :
Other physical details ill., figs., tables.
490 1# - SERIES STATEMENT
Series statement McGraw-Hill's AccessPharmacy
490 1# - SERIES STATEMENT
Series statement A Lange medical book
500 ## - GENERAL NOTE
General note "A Lange medical book."
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and indexes.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Section I. General Concepts -- CHAPTER 1. Developing Perspectives on Pharmacogenomics -- CHAPTER 2. Genetic Concepts of Pharmacogenomics: Basic Review of DNA, Genes, Polymorphisms, Haplotypes and Nomenclature -- CHAPTER 3. Analytical Methods to Identify Genetic Variations and Bioinformatics -- CHAPTER 4. Regulatory Considerations in Pharmacogenomics at EMA and US FDA -- CHAPTER 5. Ethical, Legal, and Social Issues Associated with Pharmacogenomics -- CHAPTER 6A. Pharmacogenetics of Cytochrome P450 -- CHAPTER 6B. Phase II Drug-Metabolizing Enzymes -- CHAPTER 7. Drug Transporters -- CHAPTER 8. Nongenetic Influences on Drug Metabolism -- CHAPTER 9. Public Access to Pharmacogenomic Testing and Patient Counseling -- CHAPTER 10. Understanding the Use of Pharmacoeconomic Analysis to Assess the Economic Impact of Pharmacogenomic Testing --Section II. Clinical Application of Pharmacogenomics -- CHAPTER 11. Cardiovascular Pharmacogenomics -- CHAPTER 12. Pharmacogenomics and Pharmacogenetics for Infectious Diseases -- CHAPTER 13. Pharmacogenomics in Oncology -- CHAPTER 14. Psychiatry and Addiction Medicine -- CHAPTER 15. Immunology, Transplantation, and Vaccines -- CHAPTER 16. Pharmacogenomics in Neurology -- CHAPTER 17A. Pharmacogenomics of Gastrointestinal Drugs: Focus on Proton Pump Inhibitors -- CHAPTER 17B. Genomics and the Kidney.
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Also issued in online and PDF version.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on cover image and table of contents, viewed on Oct. 24, 2016.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacogenomics
Form subdivision Textbooks.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacogenetics.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Preparations
General subdivision metabolism.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacological Phenomena
General subdivision genetics.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bertino, Joseph S.,
Relator term ed.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name DeVane, Lindsay C.,
Relator term ed.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kashuba, Angela D. M.,
Relator term ed.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ma, Joseph D.,
Relator term ed.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Online version:
Title Pharmacogenomics, an introduction and clinical perspective.
Place, publisher, and date of publication New York, N.Y. : McGraw-Hill Education LLC.,
Qualifying information 2013.
International Standard Book Number 9780071741699.
Record control number (OCoLC)793223356
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title McGraw-Hill's AccessPharmacy.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title A Lange medical book.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://accesspharmacy.mhmedical.com/book.aspx?bookid=511">http://accesspharmacy.mhmedical.com/book.aspx?bookid=511</a>

No items available.

Implemented & Customized by: BestBookBuddies

Powered by Koha